• FirefoxInstall the new Firefox »
  •  Dow Down 1.37% Nasdaq Down 0.93%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    28.01 Down 0.31(1.09%) 1:08PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:28.32
    Open:28.18
    Bid:27.88 x 200
    Ask:27.91 x 500
    1y Target Est:26.83
    Beta:-0.07
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:27.52 - 28.76
    52wk Range:19.10 - 58.08
    Volume:494,178
    Avg Vol (3m):692,988
    Market Cap:799.38M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 1.09%799.38M
    AZNDown 2.71%83.77B
    MRKDown 1.54%162.02B
    PFEDown 1.45%208.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.10
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.18
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-4.71

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback